Results From RA Clinical Trials* Prove XELJANZ Can:
2 weeks †
less RA fatigue
For others it could take up to three months or longer. Individual results may vary.
Adult patients with moderate to severe RA were evaluated in clinical trials. Some patients in the clinical studies were taking background medicines such as methotrexate and some were not. Some studies evaluated patients when other medicines such as methotrexate or TNF blockers did not work well or could not be tolerated. XELJANZ is approved for use in patients when TNF blockers did not work well or could not be tolerated.
Picture Everyday Moments with Family and Friends
How XELJANZ Works
XELJANZ is a Janus kinase (JAK) inhibitor that helps regulate an overactive immune system. It helps disrupt JAK pathways from inside the cells, which are believed to play a role in inflammation.
XELJANZ helps reduce inflammation, a cause of permanent joint damage.
patients in focus
A Closer Look at Real Patient Stories
Learn more about real adult XELJANZ patients with moderate to severe rheumatoid arthritis (RA), active psoriatic arthritis (PsA), or moderate to severe ulcerative colitis (UC). They were prescribed XELJANZ after TNF blockers did not work well or could not be tolerated. As ambassadors, they share their treatment stories to remind you that you’re not alone. Individual results may vary. Patient ambassador stories have been created in partnership with Pfizer.
Symptoms of Rheumatoid Arthritis
Take A Closer Look At How The Progression Of RA Can Cause Permanent Joint Damage
Want To Learn More About RA? Get Facts
Symptoms of Rheumatoid Arthritis
A pannus begins to form that can lead to the destruction of articular cartilage exposing the bone beneath it.
Want To Learn More About RA? Get Facts
Symptoms of Rheumatoid Arthritis
In extreme instances, pannus may invade the joint further, resulting in fibrous ankylosis and possibly even bony ankylosis. Though rare because RA is not often left untreated, this condition may lead to decreased range of motion.
Want To Learn More About RA? Get Facts
These images of potential disease symptoms are for illustrative purposes only and are not intended to be fully anatomically accurate.
Working With Your Doctor
If your current treatment isn't working well enough to manage your RA symptoms, it's important to have an open and honest discussion with your doctor. Every appointment is an opportunity to improve the dialogue with your doctor and discuss how to manage your RA. Ready to make an appointment? Find A Healthcare Provider near you.
Prepare
Before your next appointment, get ready for the conversation by reflecting on your current treatment plan and tracking your recent symptoms. The information could be helpful in finding a treatment plan that may work best for you.
Share
It may help make it easier to talk about if you write down any questions or concerns you may have ahead of your appointment to give your doctor a complete picture of your situation.
Align
Communicate with your healthcare team to help them understand your goals, concerns, and expectations. This conversation will be useful in getting everyone on the same page.
Discover RA Support Resources
Whether you want to learn more about XELJANZ or have already been prescribed it for your moderate to severe RA, we can provide you with tools and support resources. We'll start by sending you a Welcome Kit in the mail and follow up with additional communications containing timely information and lifestyle tips.
Share Your Story
Share your story and help other adults learn about your experiences with moderate to severe rheumatoid arthritis and XELJANZ. Learning about your experience may be helpful for patients who are considering treatment or have already started.
If selected, your story may appear on XELJANZ.com and/or in other marketing materials.
Easy-To-Open Bottle
The easy-to-open XELJANZ bottle cap has received an Arthritis Foundation Ease-of-Use Commendation.‡
The Arthritis Foundation's Ease of Use Commendation recognizes products, such as the XELJANZ bottle cap, which are intended to make certain tasks easier for people who have arthritis and other physical limitations.
Learn more at arthritis.org.
‡This website is neither owned nor controlled by Pfizer. Pfizer does not endorse and is not responsible for the content or services of this site.